Follow on Google News News By Tag * Critical Limb Ischemia * Healthcare Industry * Healthcare Market Research * Market Research Reports * Life Sciences Industry * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News |  Get 20% Disc. on Critical Limb Ischemia-Pipeline Insights, 2014Bharatbook.com announces 20% disc.on reports,which combine industry expertise with innovation by collecting,analyzing & communicating to deliver critical information to leading decision makers in drugs market.Hurry Up!!!(Offer valid till 26 Dec.2014)
By: Bharat Book Bureau SUMMARY 'Critical Limb Ischemia-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Critical Limb Ischemia. This report provides information on the therapeutic development based on the Critical Limb Ischemia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Scope • The report provides a snapshot of the global therapeutic landscape of Critical Limb Ischemia • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information • Coverage of the Critical Limb Ischemia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type • The report reviews key players involved in the therapeutics development for Critical Limb Ischemia and also provide company profiling • The report also gives the information of dormant and discontinued pipeline projects • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type Reasons to buy • Complete Pipeline intelligence and complete understanding over therapeutics development for Critical Limb Ischemia • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. • Devise corrective measures for pipeline projects by understanding Critical Limb Ischemia pipeline depth and focus of Indication therapeutics • Developing strategic initiatives to support your drug development activities. • Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business. • Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline • Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions Table of Contents: • Critical Limb Ischemia Overview • Critical Limb Ischemia Pipeline Therapeutics • Critical Limb Ischemia Therapeutics under Development by Companies • Critical Limb Ischemia Late Stage Products (Filed and Phase III) • Comparative Analysis • Critical Limb Ischemia Mid Clinical Stage Products (Phase II) • Comparative Analysis • Critical Limb Ischemia Early Clinical Stage Products (Phase I and IND Filed) • Comparative Analysis • Critical Limb Ischemia Discovery and Pre-Clinical Stage Products List of Tables • Number of Products under Development for Critical Limb Ischemia, 2014 • Number of Products under Development by Companies • Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014 • Comparative Analysis Mid Clinical Stage Products (Phase II), 2014 • Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014 • Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014 • Drug Candidates Profiles List of Figures • Number of Products under Development for Critical Limb Ischemia, 2014 • Late Clinical Stage Products (Filed and Phase III), 2014 • Mid Clinical Stage Products (Phase II), 2014 • Early Clinical Stage Products (Phase I and IND Filed), 2014 • Discovery and Pre-Clinical Stage Products, 2014 For more information kindly visit: https://www.bharatbook.com/ Some Christmas Special Reports: https://www.bharatbook.com/ More discounted reports: https://www.bharatbook.com/ About Bharat Book Bureau : Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis, country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology. In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself. OR Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Email: Website: Follow us on twitter: https:// Our Blog : https:// End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number